Read article: Engines and imagers dominate awards for physics-based innovations
Biomedical imaging systems and novel engine components received top billing in the 2019 Institute of Physics Business Awards
Read article: Targeted treatment guides radiation directly to pancreatic tumours
Alpha therapy targeting a protein in the tumour stroma could provide a new treatment for pancreatic cancer
Read article: Tiny radiation beams tackle radioresistant melanoma
Microbeam radiation therapy reduces growth of radioresistant mouse melanoma by disrupting tumour vascular and stimulating the influx of immune cells
Read article: Breath-hold technique reduces patient motion during radiotherapy
New technique for performing multiple lengthy breath-holds will enable patients to hold their breath during prolonged bouts of radiotherapy
Read article: Software offers ‘sanity check’ for adapted plans in MR-guided radiotherapy
The MR-linac allows treatment plan adaption to the patient's daily anatomy – but how can we tell whether the new plan is suitable for delivery?
Read article: MRI guidance minimizes toxicity in prostate cancer radiotherapy
The first prospective study of MR-guided hypofractionated radiotherapy in prostate cancer patients demonstrates particularly low toxicity
Read article: ASTRO: highlighting radiation oncology breakthroughs
At the ASTRO Annual Meeting, researchers unveil the latest research in areas such as cardiac radioablation, immunotherapy and machine learning
Read article: Dosimetry software captures daily, cumulative patient trends
Standard Imaging’s Adaptivo software tracks and reports the dosimetric impact of changes in patient anatomy and positioning during the course of radiation treatment
Read article: Hypofractionation: a new value proposition in radiation oncology
Motion synchronization, adaptive planning and treatment versatility will unlock the full potential of hypofractionated radiotherapy for value-based cancer care
Read article: PET/CT-guided chemoradiotherapy improves lung cancer outcomes
The PERTAIN trial is examining the impact of FDG PET/CT-guided chemoradiotherapy for lung cancer patients in low- and middle-income countries
